These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9802771)

  • 1. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
    Morimoto J; Maruyama T; Kasuga A; Ozawa Y; Kobayashi A; Funakoshi S; Iwasaki R; Suzuki Y; Shimada A; Saruta T
    Diabetes Care; 1998 Nov; 21(11):2037-9. PubMed ID: 9802771
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
    Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
    Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-associated autoantibodies in aboriginal children.
    Sellers E; Eisenbarth G; Young TK; Dean HJ
    Lancet; 2000 Apr; 355(9210):1156. PubMed ID: 10791381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutamate decarboxylase: an autoantigen in IDDM.
    Clare-Salzler MJ; Tobin AJ; Kaufman DL
    Diabetes Care; 1992 Jan; 15(1):132-5. PubMed ID: 1737532
    [No Abstract]   [Full Text] [Related]  

  • 8. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 11. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!
    Rolandsson O; Palmer JP
    Diabetologia; 2010 Jul; 53(7):1250-3. PubMed ID: 20336277
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 1 diabetes islet autoantibody markers.
    Winter WE; Harris N; Schatz D
    Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
    Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y
    Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus.
    Rowley MJ; Mackay IR; Chen QY; Knowles WJ; Zimmet PZ
    Diabetes; 1992 Apr; 41(4):548-51. PubMed ID: 1607079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's insulin.
    Wegmann DR; Eisenbarth GS
    J Autoimmun; 2000 Nov; 15(3):286-91. PubMed ID: 11040069
    [No Abstract]   [Full Text] [Related]  

  • 17. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus.
    Kanungo A; Shtauvere-Brameus A; Samal KC; Sanjeevi CB
    Ann N Y Acad Sci; 2002 Apr; 958():232-4. PubMed ID: 12021113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity and insulin-dependent diabetes.
    Lowdell M; Bottazzo GF
    Lancet; 1993 May; 341(8857):1378-9. PubMed ID: 8098796
    [No Abstract]   [Full Text] [Related]  

  • 20. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.